Osiris Therapeutics(美國)

Osiris Therapeutics

美國OsirisTherapeuticswww.osiristx.com美國Osiris關注與間質干細胞地位（MSC）的技術，職前臨床，在疾病的動物模型，并在診所也。近年來，該公司贊助了一些臨床試驗，以評估產品的安全性和有效性。OsirisTherapeutics,Inc.hasfocusedontheadvancementofmesenchymalstemcell(MSC)technologie sbothpre-clinically,inanimalmodelsofdisease,andalsointheclinic.Inrecentyears,theCompanyhassponsoredanumberofclinicaltrialstoevaluateproductsafetyandefficacy.Theprimarythrustofthenear-termbusinessstrategyrevolvesaroundtheclinicaldevelopmentofproductcandidatesinavarietyofindications.Theinflammatoryprogramfocusesonprovidingsupportforbonemarrowtransplantationafterchemotherapyorradiationtherapy.Thegoalistotreatgraftversushostdisease(GvHD),alife-threateningcomplicationfollowingthereceiptofbonemarrowfromanotherindividual.ThecardiacprogramfocusesonMSCstoimproveheartfunctionfollowingmyocardialinfarction(MI)andtopreventprogressiontocongestive